Obst

Several regulation changes have been reported and were set in force during the past weeks that we like to point your attention to. For details please refer to the original sources via the links offered below.

Commission Regulation (EU) 2017/170

Commission Regulation (EU) 2017/170 of 30 January 2017 amending Annexes II, III and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for bifenthrin, carbetamide, cinidon-ethyl, fenpropimorph and triflusulfuron in or on certain products.

 

Valid from 23.8.2017 are the following changes with few exception (cf. (EU) 2017/170)

 

Please have a look at this Excel-File.

 

For further details please refer directly to the EU regulation!

Commision Regulation (EU) 2017/171

Commission Regulation (EU) 2017/171 of 30 January 2017 amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for aminopyralid, azoxystrobin, cyantraniliprole, cyflufenamid, cyproconazole, diethofencarb, dithiocarbamates, fluazifop-P, fluopyram, haloxyfop, isofetamid, metalaxyl, prohexadione, propaquizafop, pyrimethanil, Trichoderma atroviride strain SC1 and zoxamide in or on certain products.

 

Please have a look at this Excel-File.